You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

Welcome to ADVENT!

What do you want to know about type 2 inflammatory diseases?

No matches

ADVENT is a medical education program designed to advance the understanding of type 2 inflammation. ADVENT is developed in collaboration with over 50 global experts and links the latest science of type 2 inflammation with the clinical experience to improve patient care.

Educational resources

Check the new ADVENT EoE Learning Hub page to learn more about the pathophysiology, disease burden and management of EoE featuring educational resources.

On demand event highlights

Join experts Prof. Salvatore Oliva and Dr. Milli Gupta for an educational symposium on the on type 2 inflammation in EoE.

4 assets

UEGW 2024 | Something to Chew On: Exploring Biologics in EoE Management

Prof. Salvatore Oliva and Dr. Milli Gupta discuss the importance of long-term care, multidimensional assessment, and the latest data for biologics.

5 assets

ERS 2024 | Targeting IL-33 in COPD: Exploring New Frontiers for COPD Management

Engage with experts Klaus Rabe, Stephanie Christenson, and Paola Rogliani in an educational symposium to explore the inflammatory pathways and phenotypes of COPD, investigate the genetic associations of IL-33 and COPD, examine early preclinical findings, and review ongoing research on the role of IL-33 in COPD.

Join Profs. Eric Simpson, Stephan Weidinger, and Marjolein de Bruin-Weller for an educational symposium exploring the local and systemic effects of type 2 inflammation in AD and potential benefits of early intervention with regard to disease modification.

1 assets

Early Intervention and Disease Modification in AD: Can We Change the Course of the Disease?

Highlights from the ADVENT educational symposium at EADV 2024 where Professors Eric Simpson, Stephan Weidinger, and Marjolein de Bruin-Weller explored the local and systemic effects of type 2 inflammation in AD and potential benefits of early intervention with regard to disease modification.

4 assets

ERS 2024 | A Breath of Fresh Air: A Greater Understanding of COPD With Type 2 Inflammation

Join experts Henrik Watz, Mona Bafadhel, and Alberto Papi for an educational symposium on the link between underlying drivers of COPD with type 2 inflammation and cumulative patient burden, exploring the role of type 2 cytokines, and current and emerging therapies.

4 assets

ERS 2024 | Airway Remodeling: A Permanent or Transitory Consequence in Severe Asthma Patients?

Join Klaus Rabe, MD, PhD, FERS; Celeste Porsberg, MD, PhD; and Mario Castro, MD, MPH, for a symposium on airway remodeling in severe asthma patients.

4 assets

SPD | Shifting Gears: Can Disease Course Be Changed in Patients With Pediatric Atopic Dermatitis?

Drs. Amy Paller and Peter Lio led an educational symposium that investigated atopic dermatitis as a risk factor for the development of food allergies. The speakers also discussed the benefits of early intervention in pediatric atopic dermatitis and the potential for disease modification.

8 assets

ESPD 2024 | Atopic Dermatitis in Children: Can Early Therapeutic Intervention Shape Disease Course?

This symposium illustrated the ways type 2inflammation contributes to atopic dermatitis (AD) disease pathogenesis within and beyond the skin, discussed the importance of early intervention in children with AD, and explored the potential for disease modification. The program concluded with a review of the latest clinical and real-world data on advanced systemic treatments for children with AD.

4 assets

ESPGHAN 2024 | Shedding Light on Pediatric Eosinophilic Esophagitis: Timely Identification and Management

Prof. Salvatore Oliva and Dr. Dhandapani Ashok discuss the burden of type 2 inflammation in pediatric EoE and the importance of early diagnosis and management.

5 assets

Global CRSwNP Awareness Day 2024

Explore resources on the importance of partnering with patients to empower them to take an active role in their care.

9 assets

IRS-ISIAN 2024 | Evolving Perspectives in CRSwNP: From Symptom Control to Disease Remission

Presentation highlights from the ADVENT symposium on disease remission in CRSwNP at the 42nd Congress of the International Society of Inflammation and Allergy of the Nose and 24th Congress of the International Rhinologic Society in Tokyo, Japan.

1 assets

Lung Function White Board Videos

Explore our educational resources about the importance of lung function assessment in severe Adult and Pediatric Asthma.

4 assets

IRS-ISIAN 2024 | The Importance of Understanding Smell Loss and Congestion in CRSwNP

Presentation highlights from the ADVENT symposium on smell loss and nasal congestion in CRSwNP at the 42nd Congress of the International Society of Inflammation and Allergy of the Nose and 24th Congress of the International Rhinologic Society in Tokyo, Japan.

9 assets

The Benefits of Early Intervention In AD: More Than Skin Deep

Many AD treatment goals focus on clinical manifestations, so that if a patient is free of lesions, their disease is considered well controlled. However, the inflammatory process underlying AD reaches far beyond the skin, affecting patients in unique ways at different stages of their lives. Education on the importance of treating AD beyond the skin and altering the treatment approach to fit the individual patient will help improve clinical management and reduce long-term patient burden.

2 assets

Anosmia Awareness Day 2024

Explore our educational resources about loss of smell and the role of type 2 inflammation in CRSwNP, featuring expert insights from Prof. Wytske Fokkens, Dr. Stella Lee, and Prof. Joaquim Mullol, among others.

17 assets

UCARE 2023 Symposium: Targeting Type 2 Inflammation in CSU – Clinical and Mechanistic Implications

Exploring the role of type 2 inflammation and the neuroimmune axis in CSU, and how emerging therapeutics are targeting key molecules in these pathways.

8 assets

Global ADVENT FORUM 2023, Dermatology Plenary 1: Itch: The Common Thread in Dermatological Type 2 Inflammation (AD, PN, & CSU)

A review of the shared and unique neuroimmune mechanisms in the generation of itch across AD, PN, and CSU.

13 assets

Global ADVENT FORUM 2023, Dermatology Plenary 2: New Perspectives on Disease Modification in Atopic Dermatitis

An exploration into the concept and potential of disease modification through therapeutic interventions in AD.

5 assets

Global ADVENT FORUM 2023, Dermatology Plenary 3: Updates in PN and CSU: Emerging Therapeutic Landscapes and Implications for Patient Management

A review of disease burden and treatment needs in PN and CSU, and how current and emerging therapies can impact patient management in these respective diseases.

7 assets

ISDS 2023: Navigating Recent Scientific Advances in Atopic Dermatitis: Skin Barrier Dysfunction, Dysbiosis, and Itch

Highlights from the ADVENT symposium at the Inflammatory Skin Disease Summit (ISDS) 2023 exploring the role of type 2 inflammation in atopic dermatitis

6 assets

World Congress on Itch 2023 Symposium: Itch in AD, PN, and CSU: Underlying Mechanisms and the Role of Type 2 Inflammation

Exploration of the shared mechanisms of itch across AD, PN, and CSU as well as the distinct ways itch manifests in each disease.

5 assets

UEG Week 2023 | Expanding Horizons in EoE: The Journey to Long-term Disease Control

Join Prof. Christoph Schlag and Dr. Christoper Ma for an educational presentation about the journey to long-term disease control in EoE.

5 assets

UEG Week 2023 | Expanding Horizons in EoE: The Journey to Long-term Disease Control

On-demand content from the ADVENT EoE symposium at UEG Week 2023 is now available! Join Prof. Christoph Schlag and Dr. Christoper Ma for an educational presentation about the journey to long-term disease control in EoE.

8 assets

EADV 2023 Symposium: Emerging Understanding of Chronic Itchy Skin Diseases: Shared and Unique Drivers in AD, PN, and CSU

Review the roles of type 2 inflammation in the skin manifestations and itch in these chronic skin conditions.

7 assets

EADV 2023 Symposium: Exploring Prurigo Nodularis: From Definition to Pathology and Patient Management

Drs. Chih-Ho Hong, Sarina Elmariah and Brian Kim, and Prof. Sonja Ständer explored prurigo nodularis from definition to pathology and patient management.

7 assets

EADV 2023 Symposium: New Horizons in Children With Atopic Dermatitis: Emerging Evidence in Disease Management

Review the evolving therapeutic landscape for children with AD, considering clinically relevant data supporting the use of advanced systemic therapies.

6 assets

ERS 2023 | Adult Asthma Symposium | Evolving Patient Care: From Symptom Control to On-Treatment Clinical Remission

The ADVENT adult asthma symposium at ERS 2023 is now available on demand

5 assets

ERS 2023 | Pediatric Asthma Symposium | On-Therapy Remission in Pediatric Asthma: Where Are We Today?

The ADVENT pediatric asthma symposium presented at ERS 2023 is now available on demand.

15 assets

ADVENT at 25th World Congress of Dermatology, WCD 2023 Highlights

See highlights of ADVENT symposia at WCD congress 2023

5 assets

WCD 2023 Symposium: IL-4 and IL-13: Shared and Unique Roles in Atopic Dermatitis (AD) and Prurigo Nodularis (PN)

Highlights from the WCD 2023 ADVENT symposium, exploring the distinctions and shared elements of atopic dermatitis and prurigo nodularis.

10 assets

WCD 2023 Symposium: Atopic Dermatitis (AD) in Children: Early Intervention Can Reduce Long-Term Disease Impact

Highlights from the 2023 World Congress of Dermatology ADVENT symposium, exploring intervention considerations for children with atopic dermatitis.

4 assets

ERS-ISIAN 2023 | Optimizing Patient Outcomes in CRSwNP: Guidelines and Shared Decision-Making

Prof. Peter Hellings and Dr. Stella Lee discuss the current landscape of CRSwNP guidelines and treatment for optimizing patient outcomes.

4 assets

EAACI 2023 Symposium: Targeting Type 2 Inflammation in Children With Atopic Dermatitis: Opportunity for Early Intervention?

Presentations from the ADVENT symposium at the EAACI 2023 congress on targeting type 2 Inflammation in children with atopic dermatitis.

3 assets

EAACI 2023 | Pediatric Asthma Symposium | Pediatric Severe Asthma: Why Lung Function Matters

Join Prof. Monika Gappa and Dr. Leonard Bacharier as they explore the importance of lung function in pediatric asthma disease progression.

4 assets

EAACI 2023 | Type 2 Symposium | Pediatric Type 2 Inflammatory Disease Progression

Dr. Leonard Bacharier and Profs. Oscar Palomares and Stephan Weidinger explore shared features of type 2 pathophysiology in AD, asthma, and EoE, and disease burden in pediatric patients.

4 assets

ESPGHAN 2023 | Growing Up With EoE: Patient Care From Adolescence to Adulthood

Dr. Noam Zevit and Prof. Salvatore Oliva review the patient burden, impact on quality of life, and management options for adolescents with EoE.

4 assets

ISID 2023 Symposium: Skin Barrier, Neuroimmune Axis, and Type 2 Inflammation in Atopic Dermatitis

Presentations from the ADVENT symposium at the ISID 2023 meeting on the skin barrier, neuroimmune axis, and type 2 inflammation in atopic dermatitis.

3 assets

ESPD 2023 Symposium Presentation: Early Intervention in Children With Atopic Dermatitis: A Window of Opportunity?

Highlights from the ESPD 2023 ADVENT symposium, exploring burden, skin barrier normalization and current treatments for pediatric atopic dermatitis.

10 assets

AAD Meeting 2023: Prurigo Nodularis and Atopic Dermatitis: Distinct Diseases With Shared and Unique Roles for Type 2 Inflammation

Highlights from the ADVENT symposium at AAD 2023 on the shared and unique roles of type 2 inflammation in atopic dermatitis and prurigo nodularis.

4 assets

IFOS 2023 | Type 2 Inflammation and Clinically Relevant Improvements in CRSwNP

Dr. Stella Lee and Profs. Peter Hellings and Wytske Fokkens discuss type 2 inflammation, partnering with patients to improve outcomes, and real-world data on biologic effectiveness in CRSwNP.

Explore all educational resources

Upcoming events

7March2025

Congress

ADVENT in Orlando, 2025

Type 2 inflammation contributes to many dermatologic diseases, which may lead to potentially life-changing burdens and challenges to patients and caregivers. By uncovering the role of type 2 inflammation in the pathophysiology of AD, PN, CSU, and BP, we can move forward in our understanding of each disease. Join global experts for an educational symposium on March 8th that will uncover the role of type 2 inflammation in the pathophysiology of AD, PN, CSU, and BP and explore questions driving current research in each disease.

Future events

7March2025

Congress

ADVENT in Orlando, 2025

Sign up to ADVENT

ADVENT is a medical education program dedicated to Type 2 Inflammation across multiple therapeutic areas. Registering for ADVENT is free and unlocks unlimited access to exclusive features and a wealth of content relevant to the practice of Dermatology, Pulmonology, Rhinology, and Gastroenterology. Sign up now!

Hear from ADVENT experts

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: GermanyChange country/region

On demand event highlights

4 assets

UEGW 2024 | Something to Chew On: Exploring Biologics in EoE Management

Prof. Salvatore Oliva and Dr. Milli Gupta discuss the importance of long-term care, multidimensional assessment, and the latest data for biologics.

5 assets

ERS 2024 | Targeting IL-33 in COPD: Exploring New Frontiers for COPD Management

1 assets

Early Intervention and Disease Modification in AD: Can We Change the Course of the Disease?

4 assets

ERS 2024 | A Breath of Fresh Air: A Greater Understanding of COPD With Type 2 Inflammation

4 assets

ERS 2024 | Airway Remodeling: A Permanent or Transitory Consequence in Severe Asthma Patients?

Join Klaus Rabe, MD, PhD, FERS; Celeste Porsberg, MD, PhD; and Mario Castro, MD, MPH, for a symposium on airway remodeling in severe asthma patients.

4 assets

SPD | Shifting Gears: Can Disease Course Be Changed in Patients With Pediatric Atopic Dermatitis?

8 assets

ESPD 2024 | Atopic Dermatitis in Children: Can Early Therapeutic Intervention Shape Disease Course?

4 assets

ESPGHAN 2024 | Shedding Light on Pediatric Eosinophilic Esophagitis: Timely Identification and Management

Prof. Salvatore Oliva and Dr. Dhandapani Ashok discuss the burden of type 2 inflammation in pediatric EoE and the importance of early diagnosis and management.

5 assets

Global CRSwNP Awareness Day 2024

Explore resources on the importance of partnering with patients to empower them to take an active role in their care.

9 assets

IRS-ISIAN 2024 | Evolving Perspectives in CRSwNP: From Symptom Control to Disease Remission

1 assets

Lung Function White Board Videos

Explore our educational resources about the importance of lung function assessment in severe Adult and Pediatric Asthma.

4 assets

IRS-ISIAN 2024 | The Importance of Understanding Smell Loss and Congestion in CRSwNP

9 assets

The Benefits of Early Intervention In AD: More Than Skin Deep

2 assets

Anosmia Awareness Day 2024

17 assets

UCARE 2023 Symposium: Targeting Type 2 Inflammation in CSU – Clinical and Mechanistic Implications

Exploring the role of type 2 inflammation and the neuroimmune axis in CSU, and how emerging therapeutics are targeting key molecules in these pathways.

8 assets

Global ADVENT FORUM 2023, Dermatology Plenary 1: Itch: The Common Thread in Dermatological Type 2 Inflammation (AD, PN, & CSU)

A review of the shared and unique neuroimmune mechanisms in the generation of itch across AD, PN, and CSU.

13 assets

Global ADVENT FORUM 2023, Dermatology Plenary 2: New Perspectives on Disease Modification in Atopic Dermatitis

An exploration into the concept and potential of disease modification through therapeutic interventions in AD.

5 assets

Global ADVENT FORUM 2023, Dermatology Plenary 3: Updates in PN and CSU: Emerging Therapeutic Landscapes and Implications for Patient Management

A review of disease burden and treatment needs in PN and CSU, and how current and emerging therapies can impact patient management in these respective diseases.

7 assets

ISDS 2023: Navigating Recent Scientific Advances in Atopic Dermatitis: Skin Barrier Dysfunction, Dysbiosis, and Itch

Highlights from the ADVENT symposium at the Inflammatory Skin Disease Summit (ISDS) 2023 exploring the role of type 2 inflammation in atopic dermatitis

6 assets

World Congress on Itch 2023 Symposium: Itch in AD, PN, and CSU: Underlying Mechanisms and the Role of Type 2 Inflammation

Exploration of the shared mechanisms of itch across AD, PN, and CSU as well as the distinct ways itch manifests in each disease.

5 assets

UEG Week 2023 | Expanding Horizons in EoE: The Journey to Long-term Disease Control

Join Prof. Christoph Schlag and Dr. Christoper Ma for an educational presentation about the journey to long-term disease control in EoE.

5 assets

UEG Week 2023 | Expanding Horizons in EoE: The Journey to Long-term Disease Control

8 assets

EADV 2023 Symposium: Emerging Understanding of Chronic Itchy Skin Diseases: Shared and Unique Drivers in AD, PN, and CSU

Review the roles of type 2 inflammation in the skin manifestations and itch in these chronic skin conditions.

7 assets

EADV 2023 Symposium: Exploring Prurigo Nodularis: From Definition to Pathology and Patient Management

Drs. Chih-Ho Hong, Sarina Elmariah and Brian Kim, and Prof. Sonja Ständer explored prurigo nodularis from definition to pathology and patient management.

7 assets

EADV 2023 Symposium: New Horizons in Children With Atopic Dermatitis: Emerging Evidence in Disease Management

Review the evolving therapeutic landscape for children with AD, considering clinically relevant data supporting the use of advanced systemic therapies.

6 assets

ERS 2023 | Adult Asthma Symposium | Evolving Patient Care: From Symptom Control to On-Treatment Clinical Remission

The ADVENT adult asthma symposium at ERS 2023 is now available on demand

5 assets

ERS 2023 | Pediatric Asthma Symposium | On-Therapy Remission in Pediatric Asthma: Where Are We Today?

The ADVENT pediatric asthma symposium presented at ERS 2023 is now available on demand.

15 assets

ADVENT at 25th World Congress of Dermatology, WCD 2023 Highlights

See highlights of ADVENT symposia at WCD congress 2023

5 assets

WCD 2023 Symposium: IL-4 and IL-13: Shared and Unique Roles in Atopic Dermatitis (AD) and Prurigo Nodularis (PN)

Highlights from the WCD 2023 ADVENT symposium, exploring the distinctions and shared elements of atopic dermatitis and prurigo nodularis.

10 assets

WCD 2023 Symposium: Atopic Dermatitis (AD) in Children: Early Intervention Can Reduce Long-Term Disease Impact

Highlights from the 2023 World Congress of Dermatology ADVENT symposium, exploring intervention considerations for children with atopic dermatitis.

4 assets

ERS-ISIAN 2023 | Optimizing Patient Outcomes in CRSwNP: Guidelines and Shared Decision-Making

Prof. Peter Hellings and Dr. Stella Lee discuss the current landscape of CRSwNP guidelines and treatment for optimizing patient outcomes.

4 assets

EAACI 2023 Symposium: Targeting Type 2 Inflammation in Children With Atopic Dermatitis: Opportunity for Early Intervention?

Presentations from the ADVENT symposium at the EAACI 2023 congress on targeting type 2 Inflammation in children with atopic dermatitis.

3 assets

EAACI 2023 | Pediatric Asthma Symposium | Pediatric Severe Asthma: Why Lung Function Matters

Join Prof. Monika Gappa and Dr. Leonard Bacharier as they explore the importance of lung function in pediatric asthma disease progression.

4 assets

EAACI 2023 | Type 2 Symposium | Pediatric Type 2 Inflammatory Disease Progression

Dr. Leonard Bacharier and Profs. Oscar Palomares and Stephan Weidinger explore shared features of type 2 pathophysiology in AD, asthma, and EoE, and disease burden in pediatric patients.

4 assets

ESPGHAN 2023 | Growing Up With EoE: Patient Care From Adolescence to Adulthood

Dr. Noam Zevit and Prof. Salvatore Oliva review the patient burden, impact on quality of life, and management options for adolescents with EoE.

4 assets

ISID 2023 Symposium: Skin Barrier, Neuroimmune Axis, and Type 2 Inflammation in Atopic Dermatitis

Presentations from the ADVENT symposium at the ISID 2023 meeting on the skin barrier, neuroimmune axis, and type 2 inflammation in atopic dermatitis.

3 assets

ESPD 2023 Symposium Presentation: Early Intervention in Children With Atopic Dermatitis: A Window of Opportunity?

Highlights from the ESPD 2023 ADVENT symposium, exploring burden, skin barrier normalization and current treatments for pediatric atopic dermatitis.

10 assets

AAD Meeting 2023: Prurigo Nodularis and Atopic Dermatitis: Distinct Diseases With Shared and Unique Roles for Type 2 Inflammation

Highlights from the ADVENT symposium at AAD 2023 on the shared and unique roles of type 2 inflammation in atopic dermatitis and prurigo nodularis.

4 assets

IFOS 2023 | Type 2 Inflammation and Clinically Relevant Improvements in CRSwNP

Dr. Stella Lee and Profs. Peter Hellings and Wytske Fokkens discuss type 2 inflammation, partnering with patients to improve outcomes, and real-world data on biologic effectiveness in CRSwNP.

Explore all educational resources

Welcome to ADVENT!

Educational resources

Recently added

CRSwNP Triathlon: An Interactive Learning Experience

Partnering With Patients: Scores That Matter in CRSwNP

Loss of Smell is a Key Symptom of CRSwNP

Tailored Medicine in COPD: Understanding Phenotypes, Endotypes, and Genotypes

Understanding IL-33: A Key Factor in COPD Pathogenesis

CCL17 (TARC): A Key Player and Biomarker in Atopic Dermatitis

Eosinophilic Esophagitis (EoE) Pediatric Interactive Patient Case

Current and Emerging Therapeutic Options for Children With Atopic Dermatitis

Atopic Dermatitis in Children: Not Just a Skin Disease

Type 2 Inflammation and Its Role in Atopic Dermatitis

ADVENT On Air | Expert Discussions in Dermatology

UEGW 2024 | WHAT Can Be Used to Monitor Treatment Response in EoE and WHEN?

UEGW 2024 | Something to Chew On: Exploring Biologics in EoE Management

UEGW 2024 | Latest Clinical Evidence for Biologics in EoE

UEGW 2024 | WHY Is Long-Term Management of EoE Important?

Type 2 Inflammation in AD Manifestations in Skin and Body

Guideline-Based Diagnosis of Atopic Dermatitis

What Drives Chronic Itch and the Itch-Scratch Cycle in Atopic Dermatitis?

On demand event highlights

UEGW 2024 | Something to Chew On: Exploring Biologics in EoE Management

ERS 2024 | Targeting IL-33 in COPD: Exploring New Frontiers for COPD Management

Early Intervention and Disease Modification in AD: Can We Change the Course of the Disease?

ERS 2024 | A Breath of Fresh Air: A Greater Understanding of COPD With Type 2 Inflammation

ERS 2024 | Airway Remodeling: A Permanent or Transitory Consequence in Severe Asthma Patients?

SPD | Shifting Gears: Can Disease Course Be Changed in Patients With Pediatric Atopic Dermatitis?

ESPD 2024 | Atopic Dermatitis in Children: Can Early Therapeutic Intervention Shape Disease Course?

ESPGHAN 2024 | Shedding Light on Pediatric Eosinophilic Esophagitis: Timely Identification and Management

Global CRSwNP Awareness Day 2024

IRS-ISIAN 2024 | Evolving Perspectives in CRSwNP: From Symptom Control to Disease Remission

Lung Function White Board Videos

IRS-ISIAN 2024 | The Importance of Understanding Smell Loss and Congestion in CRSwNP

The Benefits of Early Intervention In AD: More Than Skin Deep

Anosmia Awareness Day 2024

UCARE 2023 Symposium: Targeting Type 2 Inflammation in CSU – Clinical and Mechanistic Implications

Global ADVENT FORUM 2023, Dermatology Plenary 1: Itch: The Common Thread in Dermatological Type 2 Inflammation (AD, PN, & CSU)​

Global ADVENT FORUM 2023, Dermatology Plenary 2: New Perspectives on Disease Modification in Atopic Dermatitis

Global ADVENT FORUM 2023, Dermatology Plenary 3: Updates in PN and CSU: Emerging Therapeutic Landscapes and Implications for Patient Management

ISDS 2023: Navigating Recent Scientific Advances in Atopic Dermatitis: Skin Barrier Dysfunction, Dysbiosis, and Itch

World Congress on Itch 2023 Symposium: Itch in AD, PN, and CSU: Underlying Mechanisms and the Role of Type 2 Inflammation

UEG Week 2023 | Expanding Horizons in EoE: The Journey to Long-term Disease Control

UEG Week 2023 | Expanding Horizons in EoE: The Journey to Long-term Disease Control

EADV 2023 Symposium: Emerging Understanding of Chronic Itchy Skin Diseases: Shared and Unique Drivers in AD, PN, and CSU

EADV 2023 Symposium: Exploring Prurigo Nodularis: From Definition to Pathology and Patient Management

EADV 2023 Symposium: New Horizons in Children With Atopic Dermatitis: Emerging Evidence in Disease Management

ERS 2023 | Adult Asthma Symposium | Evolving Patient Care: From Symptom Control to On-Treatment ​Clinical Remission​

ERS 2023 | Pediatric Asthma Symposium | On-Therapy Remission in Pediatric Asthma: Where Are We Today?

ADVENT at 25th World Congress of Dermatology, WCD 2023 Highlights

WCD 2023 Symposium: IL-4 and IL-13: Shared and Unique Roles in Atopic Dermatitis (AD) and Prurigo Nodularis (PN)

WCD 2023 Symposium: Atopic Dermatitis (AD) in Children: Early Intervention Can Reduce Long-Term Disease Impact

ERS-ISIAN 2023 | Optimizing Patient Outcomes in CRSwNP: Guidelines and Shared Decision-Making

EAACI 2023 Symposium: Targeting Type 2 Inflammation in Children With Atopic Dermatitis: Opportunity for Early Intervention?

EAACI 2023 | Pediatric Asthma Symposium | Pediatric Severe Asthma: Why Lung Function Matters

EAACI 2023 | Type 2 Symposium | Pediatric Type 2 Inflammatory Disease Progression

ESPGHAN 2023 | Growing Up With EoE: Patient Care From Adolescence to Adulthood

ISID 2023 Symposium: Skin Barrier, Neuroimmune Axis, and Type 2 Inflammation in Atopic Dermatitis

ESPD 2023 Symposium Presentation: Early Intervention in Children With Atopic Dermatitis: A Window of Opportunity?

AAD Meeting 2023: Prurigo Nodularis and Atopic Dermatitis: Distinct Diseases With Shared and Unique Roles for Type 2 Inflammation

IFOS 2023 | Type 2 Inflammation and Clinically Relevant Improvements in CRSwNP

Upcoming events

ADVENT in Orlando, 2025

Future events

ADVENT in Orlando, 2025

Sign up to ADVENT

Hear from ADVENT experts

Meet our experts

Katrina Abuabara

Seema Aceves

Alvar Agusti

Paolo Amerio

Peter Arkwright

April Armstrong

Ulrike von Arnim

Dhandapani Ashok

Leonard Bacharier

Claus Bachert

Vibeke Backer

Mona Bafadhel

Global ADVENT FORUM 2023, Dermatology Plenary 1: Itch: The Common Thread in Dermatological Type 2 Inflammation (AD, PN, & CSU)

ERS 2023 | Adult Asthma Symposium | Evolving Patient Care: From Symptom Control to On-Treatment Clinical Remission

Global ADVENT FORUM 2023, Dermatology Plenary 1: Itch: The Common Thread in Dermatological Type 2 Inflammation (AD, PN, & CSU)

ERS 2023 | Adult Asthma Symposium | Evolving Patient Care: From Symptom Control to On-Treatment Clinical Remission